Rhinocort
Rhinocort

50.83
A generic medicine indicated for pain and inflammation and allergies. Reduces the immune response and bronchial sensitivity by decreasing the production of inflammatory mediators within the airways.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Budesonide
Reference Brand
Budesonide
Product Origin
Generic Alternative
Reference Manufacturer
AstraZeneca
Product Form
Inhaler
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief, Allergy Relief
Product Category
Nasal Corticosteroid
Pharmacological Class
Glucocorticoid
Clinical Indications
Manufacturer Description
Utilized to manage nasal allergic pathways to alleviate congestion and support airway comfort.
Mechanism of Action
Exerts local anti-inflammatory effects by inhibiting inflammatory cell migration and reducing local vascular swelling.
Route of Administration
Nasal
Onset Time
12–24 hours
Duration
24 hours
Contraindications
Hypersensitivity to budesonide
Severe Adverse Events
Nasal septal perforation — requires immediate medical attention, Adrenal suppression — requires immediate medical attention
Common Side Effects
Nasal irritation, Sneezing, Headache
Uncommon Side Effects
Epistaxis, Throat irritation, Nasal dryness
Drug Interactions
Ketoconazole
Pregnancy Safety Warnings
TGA Category B: Safety established in large pregnancy datasets. Breastfeeding: Compatible.
Age Restrictions
Approved for children over six years and adults.
Storage Guidelines
Store between 2°C and 25°C. Do not freeze.
Information related to Rhinocort is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to purchase Eye Care Australia - Combigan Australia